Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;24(1):10-15.
doi: 10.1136/ejhpharm-2016-001003. Epub 2016 Aug 19.

Deprescribing medicines in the acute setting to reduce the risk of falls

Vanessa Marvin  1 , Emily Ward  1 , Alan J Poots  2 , Katie Heard  1 , Arvind Rajagopalan  3 , Barry Jubraj  4
Affiliations

Deprescribing medicines in the acute setting to reduce the risk of falls

Vanessa Marvin et al. Eur J Hosp Pharm. 2017 Jan.

Abstract

Background: Falls are a common cause of morbidity and hospitalisation in older people. Inappropriate prescribing and polypharmacy contribute to falls risk in elderly patients. This study's aim was to quantify the problem and find out if medication review in the hospital setting led to deprescribing of medicines associated with falls risk.

Methods: Admissions records for elderly patients were examined to identify those whose presenting complaint included a fall. Inpatient medication charts, pharmaceutical care notes, medical notes and discharge summaries were examined to identify any falls-risk medicines from admission histories and to determine if any medication review took place, and whether or not changes were made as a result. In particular deprescribing and dose reduction details were analysed.

Results: 100 patients over 70 years old were admitted following a fall during the 2 months study period. The mean number of medicines on admission was 6.8 per patient with polypharmacy found in 62/100 (62%). One or more falls-risk medicine was found in 65/100 (65%) patients. Medicines review was carried out in 86/100 (86%) of patients, and 59/697 (8.5%) medicines were deprescribed. Pharmacist involvement in medication review led to a significant reduction in the number of falls-risk medicines per patient (p=0.002).

Conclusions: Inappropriate prescribing and polypharmacy are found frequently in elderly patients at admission following a fall. Comprehensive medicines reviews should be carried out in all such patients with the objective of deprescribing or reducing doses to minimise risk of harm. Involvement of a pharmacist improves the rate of reduction of falls-risk medicines.

Keywords: CLINICAL PHARMACY; Falls; deprescribing; hospital; medication review; quality improvement.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Comment in

  • A themed journal issue on deprescribing.
    Barnett N, Jubraj B. Barnett N, et al. Eur J Hosp Pharm. 2017 Jan;24(1):1-2. doi: 10.1136/ejhpharm-2016-001118. Eur J Hosp Pharm. 2017. PMID: 31156887 Free PMC article. No abstract available.

References

    1. National Institute for Health and Care Excellence (NICE). Falls in older people. http://pathways.nice.org.uk/pathways/falls-in-older-people (accessed 26 Jan 2016). - PubMed
    1. Oliver D, Foot C, Humphries R. Making our health and care systems fit for an ageing population. London: The King's Fund, 2014. http://www.kingsfund.org.uk/publications/making-health-care-systems-fit-... (accessed 15 Jan 2016).
    1. O'Mahony D, O'Sullivan D, Byrne S, et al. . STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015;44:213–18. 10.1093/ageing/afu145 - DOI - PMC - PubMed
    1. Jyrkkä J, Enlund H, Lavikainen P, et al. . Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 2011;20:514–22. 10.1002/pds.2116 - DOI - PubMed
    1. Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: making it safe and sound. London: The King's Fund, 2013. http://www.kingsfund.org.uk/publications/polypharmacy-and-medicines-opti... (accessed 15 Jan 2016).